Skip to content

PR-Web

Press releases worldwide

  • Home
  • Contact
  • Datenschutzerklärung
  • Legal notice

Author: Firma Institut Straumann

Straumann Group reports 12% organic revenue growth in the third quarter of 2022

Posted on 2. November 2022 by Firma Institut Straumann Posted in General Tagged bone, chf, cloud, dental, implant, neodent, orthodontics, patients, peri, plusdental, revenue, roxolid, slactive, straumann, with

Third-quarter revenue amounts to CHF 551 million, an increase of 12%, bringing revenue in the first nine months of 2022 to CHF 1.7 billion All regions performing well with LATAM leading organic growth with 21% Roxolid SLActive study highlights preclinical […]

Read More

Straumann Group reports very strong first quarter

Posted on 28. April 2022 by Firma Institut Straumann Posted in General Tagged anthogyr, axiom, bone, chf, cloud, dividend, implant, market, neodent, orthodontics, p50, patients, revenue, straumann, with

. Quarterly revenue of CHF 589 million, 27.2% organic revenue growth on previous year Strong organic double-digit growth in all regions; LATAM fastest-growing Launch of two innovative challenger brand implants, Neodent Zi and Anthogyr X3 Acquisition of a strategic minority […]

Read More

Straumann Group announces new Executive Management Board members to support growth strategy

Posted on 1. April 2022 by Firma Institut Straumann Posted in General Tagged anthogyr, bbs, compass, EMB, imd, implant, market, medentika, neodent, patients, roche, securities, statements, straumann, with

  Jason Forbes joins as Straumann Group Chief Consumer Officer, a newly created position in the Executive Management Board Sébastien Roche appointed as Chief Operations and Supply Chain Officer Changes are designed to achieve ambitious growth in line with the […]

Read More

Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion

Posted on 16. December 2021 by Firma Institut Straumann Posted in General Tagged cadcam, chf, dental, dividend, drsmile, ebit, implant, market, orthodontic, patients, revenue, smilink, statements, straumann, with

  Ambition to achieve CHF 5 billion revenue by 2030 considering an average organic growth rate of at least 10%, core EBIT margin expected to range between 25-30% in the next years depending on investment, and on continuous increase of […]

Read More

Straumann Group Capital Markets Day 2021

Posted on 3. December 20213. December 2021 by Firma Institut Straumann Posted in General Tagged ampa, any, Audio, capital, company, covid, directlink, financial, implant, media, release, straumann, travel, virtual, webcast

Straumann Group invites you to attend our Capital Markets Day 2021 on Thursday, December 16, 2021. Due to the uncertainty and travel restrictions related to the COVID-19 pandemic, it will be held in a virtual format only.  The Group is evolving from […]

Read More

Straumann Group further accelerates growth in the second quarter to deliver record first half-year result

Posted on 12. August 202115. August 2021 by Firma Institut Straumann Posted in General Tagged anthogyr, cadcam, chf, drsmile, ebit, market, neodent, orthodontic, patients, printing, revenue, statements, straumann, virtuo, with

Half-year revenue reached CHF 986 million or 63% organic growth Revenue increased by 103% to reach CHF 516 million in the second quarter, with all regions reporting impressive sales growth Strong volume growth brought core EBIT to CHF 284 million, […]

Read More

Copyright 2016. All rights reserved.


Back To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkRead more